David Shoseyov

4.2k total citations
103 papers, 2.8k citations indexed

About

David Shoseyov is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, David Shoseyov has authored 103 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 15 papers in Epidemiology. Recurrent topics in David Shoseyov's work include Cystic Fibrosis Research Advances (45 papers), Neonatal Respiratory Health Research (25 papers) and Asthma and respiratory diseases (18 papers). David Shoseyov is often cited by papers focused on Cystic Fibrosis Research Advances (45 papers), Neonatal Respiratory Health Research (25 papers) and Asthma and respiratory diseases (18 papers). David Shoseyov collaborates with scholars based in Israel, United States and United Kingdom. David Shoseyov's co-authors include Eitan Kerem, Malena Cohen‐Cymberknoh, Haim Bibi, S. Armoni, Michael Wilschanski, David Feigenbaum, Joseph Rivlin, K. Brownlee, S.P. Conway and Hannah Blau and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David Shoseyov

97 papers receiving 2.7k citations

Peers

Countries citing papers authored by David Shoseyov

Since Specialization

Citations

This map shows the geographic impact of David Shoseyov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shoseyov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shoseyov more than expected).

Fields of papers citing papers by David Shoseyov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shoseyov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shoseyov. The network helps show where David Shoseyov may publish in the future.

Co-authorship network of co-authors of David Shoseyov

This figure shows the co-authorship network connecting the top 25 collaborators of David Shoseyov. A scholar is included among the top collaborators of David Shoseyov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shoseyov. David Shoseyov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can Intravenous Caffeine Citrate Be Used for Severe Asthma Exacerbation in Children? A Retrospective Comparative Study 2025 ·Journal of Paediatrics and Child Health ·Rebecca Brooks, (unknown), (unknown), Malena Cohen‐Cymberknoh, David Shoseyov, Itai Shavit	0
2	Long-Term Pulmonary Damage in Surviving Antitoxin-Treated Mice following a Lethal Ricin Intoxication 2024 ·Toxins ·Yoav Gal, Anita Sapoznikov, Shlomi Lazar, David Shoseyov, Moshe Aftalion, Hila Gutman, (unknown), (unknown), Reinat Nevo, Reut Falach	2
3	Respiratory physiotherapy in patients with cystic fibrosis and upper limb deep vein thrombosis 2022 ·Pediatric Pulmonology ·(unknown), (unknown), David Shoseyov, S. Armoni, Alex Gileles‐Hillel, (unknown), Malena Cohen‐Cymberknoh, Oded Breuer	1
4	The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study 2022 ·Pediatric Pulmonology ·Alex Gileles‐Hillel, (unknown), Oded Breuer, Joel Reiter, (unknown), Eitan Kerem, Malena Cohen‐Cymberknoh, Patrick Stafler, Meir Mei‐Zahav, (unknown), Lea Bentur, David Shoseyov	2
5	How abnormal is the normal? Clinical characteristics of CF patients with normal FEV₁ 2021 ·Pediatric Pulmonology ·Malena Cohen‐Cymberknoh, (unknown), Silvia Gärtner, Joel Reiter, (unknown), (unknown), (unknown), (unknown), (unknown), David Shoseyov, Alex Gileles‐Hillel, Oded Breuer, Natalia Simanovsky, Eitan Kerem	5
6	Betamethasone versus dexamethasone for inpatient preschool wheezing—A case‐control study 2021 ·Pediatric Pulmonology ·Alex Gileles‐Hillel, Sharon E. Guttman, Oded Breuer, Joel Reiter, (unknown), David Shoseyov, Eitan Kerem, Malena Cohen‐Cymberknoh	0
7	Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia 2020 ·ERJ Open Research ·Alex Gileles‐Hillel, Hagar Mor‐Shaked, David Shoseyov, Joel Reiter, (unknown), Avigdor Hevroni, Malena Cohen‐Cymberknoh, Israel Amirav, Shuli Brammli‐Greenberg, Amjad Horani, Eitan Kerem, Oded Breuer	15
8	Giant lung cysts following necrotizing pneumonia: Resolution with conservative treatment 2019 ·Pediatric Pulmonology ·(unknown), Oren Gordon, Malena Cohen‐Cymberknoh, Joel Reiter, (unknown), Alex Gileles‐Hillel, (unknown), Avigdor Hevroni, David Shoseyov, Eitan Kerem	14
9	WS10.2 Adherence to study drugs in clinical trials 2014 ·Journal of Cystic Fibrosis ·Thea Pugatsch, David Shoseyov, (unknown), Eitan Kerem	2
10	Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel 2014 ·Journal of Cystic Fibrosis ·Orit Peled, (unknown), Eitan Kerem, David Shoseyov, Hannah Blau, Ori Efrati, Colin Block	2
11	Mitochondrial OXPHOS function is unaffected by chronic azithromycin treatment 2013 ·Journal of Cystic Fibrosis ·(unknown), (unknown), Ariel Tenenbaum, Malena Cohen‐Cymberknoh, David Shoseyov, Eitan Kerem, Ann Saada	9
12	Laryngeal obstruction in congenital plasminogen deficiency 2012 ·Pediatric Pulmonology ·Jonathan Cohen, (unknown), (unknown), Menachem Gross, Nir Hirshoren, David Shoseyov	2
13	Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis 2011 ·European Respiratory Journal ·Michael Wilschanski, L.L. Miller, David Shoseyov, H. Blau, Joseph Rivlin, Micha Aviram, Michael Cohen, S. Armoni, Yasmin Yaakov, (unknown), Malena Cohen‐Cymberknoh, (unknown), A. Reha, Valerie Northcutt, Samit Hirawat, K. Donnelly, Gary Elfring, Temitayo Ajayi, Eitan Kerem	151
14	Managing Cystic Fibrosis: Strategies That Increase Life Expectancy and Improve Quality of Life 2011 ·American Journal of Respiratory and Critical Care Medicine ·Malena Cohen‐Cymberknoh, David Shoseyov, Eitan Kerem	209
15	Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis 2011 ·Journal of Cystic Fibrosis ·Eitan Kerem, Michael Wilschanski, (unknown), Thea Pugatsch, (unknown), Hannah Blau, Joseph Rivlin, David Shoseyov, A. Reha, S. Constantine, Temitayo Ajayi, Samit Hirawat, Gary Elfring, Stuart W. Peltz, Langdon L. Miller	11
16	Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation 2010 ·Journal of Cystic Fibrosis ·(unknown), David Shoseyov, Eitan Kerem, David Zangen	15
17	Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis 2009 ·Journal of Cystic Fibrosis ·Malena Cohen‐Cymberknoh, Hannah Blau, David Shoseyov, Meir Mei‐Zahav, Ori Efrati, S. Armoni, Eitan Kerem	56
18	Aspergillus Bronchitis in Cystic Fibrosis 2006 ·CHEST Journal ·David Shoseyov, K. Brownlee, S.P. Conway, Eitan Kerem	134
19	Cutting Edge: Anti-Inflammatory Properties of Low Levels of IFN-γ 2002 ·The Journal of Immunology ·Liat Flaishon, Ian Topilski, David Shoseyov, Rami Hershkoviz, Elizabeth Fireman, Y Levo, Sylvia Marmor, Idit Shachar	69
20	Short-term Course and Outcome of Treatments of Pleural Empyema in Pediatric Patients 2002 ·CHEST Journal ·David Shoseyov, Haim Bibi, (unknown), (unknown), (unknown), (unknown), Channa Maayan	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact